Insider: HANLY ANN M. EVP & Chief Technology Officer - Vir Biotechnology, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 117,901 | 12 | 117,913 |
| Value | $610,727.18 | $59.67 | $610,786.85 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/24/2025 | DDS | 14,168 | Direct | COM | $9.45 | $133,935.77 | 117,901 |
| 04/01/2024 | DDS | 2,711 | Direct | COM | $10.05 | $27,250.97 | 132,069 |
| 02/22/2024 | DDS | 12,296 | Direct | COM | $10.05 | $123,520.70 | 134,780 |
| 03/30/2023 | DDS | 2,627 | Direct | COM | $22.77 | $59,816.79 | 114,576 |
| 03/30/2022 | DDS | 2,627 | Direct | COM | $26.24 | $68,925.39 | 81,473 |
| 11/29/2021 | AAP | 12 | Indirect | COM | $43.39 | $499.85 | 12 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research